Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
44.22
+0.75 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Revenue by Segment
History
| Date | Product | Other |
|---|---|---|
| Sep 30, 2024 | 265.30M | 257.40M |
| Jun 30, 2024 | 230.30M | 250.90M |
| Mar 31, 2024 | 198.70M | 243.80M |
| Dec 31, 2023 | 180.40M | 253.80M |
| Sep 30, 2023 | 157.60M | 252.60M |
| Jun 30, 2023 | 147.80M | 245.10M |
| Mar 31, 2023 | 136.40M | 237.50M |
| Dec 31, 2022 | 118.90M | 234.40M |
| Sep 30, 2022 | 110.20M | 223.00M |
| Jun 30, 2022 | 99.70M | 234.40M |
| Mar 31, 2022 | 87.20M | 244.50M |
| Dec 31, 2021 | 77.00M | 274.20M |
| Sep 30, 2021 | 69.80M | 289.70M |
| Jun 30, 2021 | 59.00M | 300.30M |
| Mar 31, 2021 | 48.80M | 285.40M |
| Dec 31, 2020 | 38.80M | 232.30M |
| Sep 30, 2020 | 33.00M | 182.10M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.